Docosahexaenoic Acid (DHA) Market Size & Share, by Type (Fish Oil DHA, Algae DHA), Form (Powder, Liquid), Application (Improving Memory, Brain Development), End-user (Breastfeeding Mothers, Infants, Pregnant Mothers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 3946
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Docosahexaenoic Acid (DHA) Market size was over USD 4.51 billion in 2024 and is anticipated to cross USD 15.39 billion by 2037, growing at more than 9.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of docosahexaenoic acid is estimated at USD 5.25 billion.

The reason behind the growth is impelled by escalating cases of depression. One such factor that sets off depression in a person is a deficiency in docosahexaenoic acid (DHA), as taking EPA and DHA Omega-3s is associated with a significant reduction in depressive symptoms. Thus, the surge in cases of depression throughout the world is anticipated to drive market growth in the coming years. As reported in the World Health Organization (WHO) 2021 report, depression affected an estimated 5% of individuals globally.

The surging risk of preterm births across the globe is believed to fuel DHA market growth. The risk of death or major disability increases with the preterm birth of a baby. For instance, by the end of 2020, over 16 million preterm births occurred globally, resulting in an 11% preterm birth rate worldwide. Along with this, premature birth is the main cause of mortality in children, responsible for up to 37% of infant deaths and nearly 19% of all deaths in children under the age of 5 years.

DHA helps in reducing the risk of preterm birth by providing essential nutrients to the fetus. Hence, the surging risk of preterm births is also estimated to spur market growth in the coming years.


Get more information on this report: Request Free Sample PDF

DHA Market: Growth Drivers and Challenges

Growth Drivers

  • Increase in Unhealthy Eating Habits - Unhealthy eating practices encompass undereating or overeating, not getting enough of the essential nutrients we need every day, or taking an excessive amount of low-fiber, high-fat, and sugar-containing foods and beverages. Such kind of food items deliver more harm to our overall health and even increases the death toll.
    The surge in unhealthy eating habits has been increasing the tendency to consume DHA as dietary supplements to get the required amount of essential nutrients for overall health, which is projected to fuel market growth. According to a global report, in 2021, nearly 49% of people ate either too little or too much.
  • Rising Disposable Income – Disposable income naturally leads to a growth in consumption. Based on Bureau of Economic Analysis data, by March 2022, personal income and disposable personal income (DPI) in the United States climbed by 107.2 billion and USD 89.7 billion respectively.

Challenges

  • Associated Side Effects of Docosahexaenoic Acid (DHA) - Though DHA is safe and very beneficial for the overall health of a person. But still, some rising side effects of DHA comprising headache, bad breath, bad taste, bloating, and so on are anticipated to limit people from consuming products containing docosahexaenoic acid. Moreover, taking DHA in the form of fish oil can also have a variety of side effects, such as heartburn, and nausea. Hence, this factor is anticipated to dampen the market growth over the projected time frame.
  • Unstable Supply of Raw Materials
  • High Cost of Concentrated DHA

Docosahexaenoic Acid Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

9.9%

Base Year Market Size (2024)

USD 4.51 billion

Forecast Year Market Size (2037)

USD 15.39 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Docosahexaenoic Acid (DHA) Segmentation

Type (Fish Oil DHA, Algae DHA)

The algae docosahexaenoic acid market is estimated to gain around 61% market share in the coming years owing to the rising application of algae-based omega-3s in infant food. Algae oil is used as a substitute to fish in baby milk and food and is considered a primary source of omega-3 fats. It is used in formulations for newborns and young children in powder form since it is high in the omega-3 fats EPA and DHA.

In addition, more than 500 human goods now employ the omega-3 oil that comes from these algae which is also known as a vegetarian source of docosahexaenoic acid.

End-User (Breastfeeding Mothers, Infants, Pregnant Mothers)

The pregnant mothers segment in the docosahexaenoic acid market is set to garner a notable share in the near future driven by the growing demand for DHA in pregnant mothers. Pregnant women must consume sufficient levels of DHA to improve the quality of their pregnancies and the health of their fetuses. A growing body of research indicates that pregnant women may benefit from taking supplements of omega-3 fatty acids, particularly DHA, which may aid in maintaining a healthy birth weight.

Our in-depth analysis of the global market includes the following segments:

     Type

  • Fish Oil DHA
  • Algae DHA

     Form

  • Powder
  • Liquid

     Application

  • Improving memory
  • Brain development

     End-User

  • Breastfeeding Mothers
  • Infants
  • Pregnant Mothers

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

DHA Industry - Regional Synopsis

APAC Market Forecast

 Asia Pacific industry is predicted to dominate majority revenue share of 42% by 2037, impelled by growing healthcare expenditure in the region. Rising healthcare spending in healthcare may increase awareness among individuals and medical professionals about the importance of DHA in maintaining overall health.

As a result, people in the region are likely to seek out products such as DHA-enriched infant formulas, baby food, and other supplements.

North American Market Statistics

The North American docosahexaenoic acid (DHA) market is estimated to be the second largest, during the forecast timeframe led by the surging numbers of consumers who have been opting for concentrated dietary supplements to address their nutritional needs for DHA. For instance, the region's population is becoming more concerned with their own health, which has led to an increase in demand for concentrated dietary supplements to meet their nutritional needs for DHA and promote their well-being.

Research Nester
Get more information on this report: Request Free Sample PDF

Companies Dominating the Docosahexaenoic Acid Market

    • Koninklijke DSM N.V.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • BASF SE
    • Croda International Plc
    • Cellana, Inc.
    • Far East Microalgae Industries, Co., Ltd.(FEMICO)
    • Pelagia AS
    • Corbion NV
    • JC Biotech Private Limited
    • Source Omega LLC
    • Shandong Yuexiang Biotechnology Co., Ltd.

In the News

  • Koninklijke DSM N.V. announced the release of its novel, high-quality life'sDHA SF55-O200DS oil for maternal and early-life nutritional solutions. This new plant-based high-potency DHA oil strengthens the company's maternal and baby nutrition range.
  • Croda International Plc acquired Solus Biotech from Solus Advanced Materials, which is a prominent provider of high-end, biotechnology-derived beauty activities.

Author Credits:  Parul Atri


  • Report ID: 3946
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of docosahexaenoic acid is estimated at USD 5.25 billion.

The docosahexaenoic acid market size was over USD 4.51 billion in 2024 and is anticipated to cross USD 15.39 billion by 2037, growing at more than 9.9% CAGR during the forecast period i.e., between 2025-2037. Escalating cases of depression and surging risk of preterm births across the globe will boost the market growth.

Asia Pacific industry is predicted to dominate majority revenue share of 42% by 2037, impelled by growing healthcare expenditure in the region.

The major players in the market are Koninklijke DSM N.V., BASF SE, Croda International Plc, Cellana, Inc., Far East Microalgae Industries, Co., Ltd.(FEMICO), Pelagia AS, Corbion NV, JC Biotech Private Limited, Source Omega LLC, Shandong Yuexiang Biotechnology Co., Ltd.
Docosahexaenoic Acid Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample